Planned Maintenance: Some services may turn out to be unavailable from 15th January, 2026 to 16th January, 2026. We apologize for the inconvenience!

7DMQ image
Deposition Date 2020-12-05
Release Date 2021-02-10
Last Version Date 2024-03-27
Entry Detail
PDB ID:
7DMQ
Title:
Cryo-EM structure of LshCas13a-crRNA-anti-tag RNA complex
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
3.06 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:CRISPR/Cas system Cas13a
Chain IDs:A
Chain Length:1391
Number of Molecules:1
Biological Source:Leptotrichia shahii
Polymer Type:polyribonucleotide
Molecule:CRISPR RNA
Chain IDs:B
Chain Length:58
Number of Molecules:1
Biological Source:Leptotrichia shahii
Polymer Type:polyribonucleotide
Molecule:Anti-tag target RNA
Chain IDs:C
Chain Length:37
Number of Molecules:1
Biological Source:Escherichia coli
Ligand Molecules
Primary Citation
Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
Mol.Cell 81 1100 ? (2021)
PMID: 33472057 DOI: 10.1016/j.molcel.2020.12.033

Abstact

Bacteria and archaea apply CRISPR-Cas surveillance complexes to defend against foreign invaders. These invading genetic elements are captured and integrated into the CRISPR array as spacer elements, guiding sequence-specific DNA/RNA targeting and cleavage. Recently, in vivo studies have shown that target RNAs with extended complementarity with repeat sequences flanking the target element (tag:anti-tag pairing) can dramatically reduce RNA cleavage by the type VI-A Cas13a system. Here, we report the cryo-EM structure of Leptotrichia shahii LshCas13acrRNA in complex with target RNA harboring tag:anti-tag pairing complementarity, with the observed conformational changes providing a molecular explanation for inactivation of the composite HEPN domain cleavage activity. These structural insights, together with in vitro biochemical and in vivo cell-based assays on key mutants, define the molecular principles underlying Cas13a's capacity to target and discriminate between self and non-self RNA targets. Our studies illuminate approaches to regulate Cas13a's cleavage activity, thereby influencing Cas13a-mediated biotechnological applications.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback